This report describes rhabdoid tumor predisposition syndrome 1, also called atypical teratoid/rhabdoid tumor. The human gene implicated in this disease is SMARCB1, which encodes a subunit of the SWI/SNF chromatin-remodeling complex. There is a single Drosophila ortholog, Snr1, for which classical loss-of-function alleles, RNAi-targeting constructs, and alleles caused by insertional mutagenesis have been generated. The human SMARCB1 gene is implicated in several other diseases (see MIM:601607), most notably Coffin-Siris syndrome 3 (MIM:614608).
The human SMARCB1 gene has not been introduced into flies.
Animals homozygous for the most severe loss-of-function alleles of Snr1 die during the embryonic or larval stages. Using RNAi constructs, ubiquitous knockdown is associated with larval lethality and increased proliferation and brain volume of the larval brain. Tissue-specific knockdown results in later stages of lethality. Using changes in the stage of lethality as an assay for genetic interactions, several members of the hippo signaling pathway were identified. Additional genetic interactions and physical interactions have been characterized; see below and in the gene report for Dmel\Snr1.
[updated Dec. 2016 by FlyBase; FBrf0222196]
[RHABDOID TUMOR PREDISPOSITION SYNDROME 1; RTPS1](https://omim.org/entry/609322)
[SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY B, MEMBER 1; SMARCB1](https://omim.org/entry/601607)
Rhabdoid tumors can arise in any location in the body but are most commonly observed in the brain (where they are called atypical teratoid/rhabdoid tumors or rhabdoid tumors of the CNS) and in the kidney (where they are called malignant rhabdoid tumors or rhabdoid tumors of the kidney) (Srendi and Tomita, 2015; pubmed:25494491).
Rhabdoid tumors are a highly malignant group of neoplasms that usually occur in children less than 2 years of age. The rhabdoid tumor predisposition syndrome is an autosomal dominant cancer syndrome predisposing to renal or extrarenal malignant rhabdoid tumors and to a variety of tumors of the central nervous system (Sevenet et al., 1999; pubmed:10521299). [from MIM:609322; 2016.12.01]
Rhabdoid tumor predisposition syndrome 1 (RTPS1) is caused by heterozygous germline mutation in the SMARCB1 gene (autosomal dominant). [from MIM:609322; 2016.12.01]
The SMARCB1 gene encodes a subunit of the SWI/SNF ATP-dependent chromatin-remodeling complex. [from MIM:601607; 2016.12.01]
One to one: 1 human to 1 Drosophila.
Ortholog of human SMARCB1 (1 Drosophila to 1 human). Dmel\Snr1 shares 63% identity and 75% similarity with human SMARCB1.